CVS vs. DHR: Which Stock Should Value Investors Buy Now?

Core Insights - CVS Health is currently rated 2 (Buy) while Danaher is rated 3 (Hold), indicating a more favorable earnings estimate revision activity for CVS [3] - Value investors assess a range of traditional metrics to determine if a company is undervalued at its current share price [3] Valuation Metrics - CVS has a forward P/E ratio of 10.54 compared to Danaher's 26.32, suggesting CVS is more attractively priced [5] - CVS's PEG ratio is 0.92, while Danaher's PEG ratio is 2.84, indicating CVS has a better growth-adjusted valuation [5] - CVS's P/B ratio stands at 1.05, significantly lower than Danaher's P/B ratio of 2.85, further supporting CVS's valuation advantage [6] - CVS's overall Value grade is A, while Danaher's Value grade is D, highlighting CVS's superior valuation metrics and earnings outlook [6]